{"collection_queue":{"director_interest":1,"holder_notice":2,"investment_release":1,"meeting_notice":9,"meeting_result":3,"security_event":22,"shareholder_list":3},"coverage":{"basis":"declared","collection_issues":[],"coverage_start":"2023-01-01","explained_count":0,"material_issue_count":0,"minor_discrepancy_count":0,"newer_pending_count":1,"note":"Reviewed the 2025 annual-report snapshot naming Dr Colin Rose and Cosoff Group as substantial shareholders. The 19 February 2026 change-in-substantial-holding filing failed verification, so later changes remain unknown.","notice_count":1,"pending_notice_count":1,"required_context_count":0,"reviewed_at":"2026-10-09T20:25:00Z","reviewed_notice_count":0,"reviewed_through":"2025-10-20","status":"partial","unclassified_note_count":0},"entities":{"aaron_brown":{"entity_id":"aaron_brown","investor_id":null,"kind":"person","management_id":null,"name":"Aaron Brown","notes":[],"relationships":[],"roles":[{"role":"Executive Director \u2013 Exploration","source_ids":["2924-03017299-2A1633061"]}]},"colin_rose":{"entity_id":"colin_rose","investor_id":null,"kind":"person","management_id":null,"name":"Dr Colin Rose","notes":[],"relationships":[{"entity_id":"mathstatica","relationship":"owner/director of related entity holding 851,316 shares, as disclosed in 2023 director notices","source_ids":["2924-02673203-2A1453252","2924-02687505-2A1461659","2924-02689535-2A1462604","2924-02698243-2A1466769"]}],"roles":[{"role":"Executive Chairman","source_ids":["2924-03017299-2A1633061"]}]},"cosoff_group":{"entity_id":"cosoff_group","investor_id":null,"kind":"reporting_group","management_id":null,"name":"Cosoff Group","notes":["Annual report does not provide a legal entity definition or account breakdown."],"relationships":[],"roles":[{"role":"substantial shareholder as reported at 20 October 2025","source_ids":["2924-03017299-2A1633061"]}]},"lisa_askham_levy":{"entity_id":"lisa_askham_levy","investor_id":null,"kind":"person","management_id":null,"name":"Lisa Askham-Levy","notes":["The May 2026 Appendix 2A identifies her as a KMP exercising options; she is not identified as a director in the reviewed annual report."],"relationships":[],"roles":[{"role":"Company Secretary, appointed 18 January 2018","source_ids":["2924-03017299-2A1633061"]}]},"mathstatica":{"entity_id":"mathstatica","investor_id":null,"kind":"company","management_id":null,"name":"Mathstatica Pty Ltd","notes":[],"relationships":[{"entity_id":"colin_rose","relationship":"held shares for which Dr Colin Rose was owner/director","source_ids":["2924-02673203-2A1453252","2924-02687505-2A1461659","2924-02689535-2A1462604","2924-02698243-2A1466769"]}],"roles":[]},"neville_bergin":{"entity_id":"neville_bergin","investor_id":null,"kind":"person","management_id":null,"name":"Neville Bergin","notes":[],"relationships":[],"roles":[{"role":"Non-executive Director \u2013 Production","source_ids":["2924-03017299-2A1633061"]}]}},"errors":[],"events":[],"facets":{"entities":["cosoff_group","colin_rose"],"event_types":[],"securities":["Fully paid ordinary shares"]},"filters":{"end":"","entity":"","security":"","start":"","type":"","view":"major_holders"},"holdings":[{"account_entity_id":null,"date":"2025-10-20","date_end":null,"entity_id":"colin_rose","holding_after":102896042,"holding_before":null,"interest_type":"not_disclosed","notes":"Annual report lists Dr Colin Rose as a substantial shareholder; percentage and account breakdown are not provided.","observation_id":"MEU-AR25-COLIN-SUBSTANTIAL","observation_type":"position","percentage":null,"percentage_basis":null,"quantity":102896042,"reconciliation_note":"","security_class":"Fully paid ordinary shares","source_refs":[{"locator":"Shareholder Information: substantial shareholders","page":79,"source_id":"2924-03017299-2A1633061"}],"supersedes":[],"view":"major_holders"},{"account_entity_id":null,"date":"2025-10-20","date_end":null,"entity_id":"cosoff_group","holding_after":69600000,"holding_before":null,"interest_type":"not_disclosed","notes":"Annual report identifies the Cosoff Group as a substantial shareholder but gives no legal structure or account breakdown.","observation_id":"MEU-AR25-COSOFF-SUBSTANTIAL","observation_type":"position","percentage":null,"percentage_basis":null,"quantity":69600000,"reconciliation_note":"","security_class":"Fully paid ordinary shares","source_refs":[{"locator":"Shareholder Information: substantial shareholders","page":79,"source_id":"2924-03017299-2A1633061"}],"supersedes":[],"view":"major_holders"}],"pending_count":41,"pending_ownership_count":3,"pending_support_count":38,"review":{"coverage_note":"Reviewed and staged the verified ASX director notices and relevant annual-report holder/director snapshots available at the cutoff. Director and major-holder coverage remain partial because holder and transaction filings failed retrieval or verification.","coverage_start":"2023-01-01","cutoff_date":"2026-10-09","download_profile":"valuation","issuer_identifier":"ABN 38 119 270 816","issuer_name":"Marmota Limited","limitations":["Prepare was partial: eight sources were available with verified PDFs; three documents failed PDF download or hash verification, and ASX issuer metadata lookup failed. The failed filings are retained in the collection queue and were not used as evidence.","The 19 February 2026 change in substantial holding could not be reviewed. The major-holder view therefore stops at the annual report snapshot dated 20 October 2025; any subsequent transaction or position change remains unknown.","The only verified director Appendix 3Y notices in the indexed window are Dr Colin Rose\u2019s four on-market purchases from May\u2013August 2023. No verified director transaction notices were available for later periods, and unindexed or failed filings may contain additional activity.","The May 2026 Appendix 2A reports exercise of 4,000,000 employee-scheme options and names Lisa Askham-Levy for 1,500,000. The annual report identifies her as Company Secretary, not a director, so no director event is recorded. The filing does not identify the holders of the remaining options; no allocation to directors is inferred.","Annual report snapshots are position disclosures only. The report lists Dr Colin Rose at 102,896,042 shares and Cosoff Group at 69,600,000 as substantial shareholders as at 20 October 2025; the unavailable February 2026 Form 604 prevents updating these positions."],"reviewed_at":"2026-10-09T20:25:00Z","schema_version":"1.1.0","ticker":"MEU","view_coverage":{"directors":{"coverage_start":"2023-01-01","note":"Reviewed the four verified 2023 director purchase notices and 2025 annual-report position schedule. Later director notices were not available in verified form; the May 2026 KMP option exercise names the Company Secretary and is not treated as a director transaction.","reviewed_at":"2026-10-09T20:25:00Z","reviewed_through":"2025-09-25","status":"partial"},"major_holders":{"coverage_start":"2023-01-01","note":"Reviewed the 2025 annual-report snapshot naming Dr Colin Rose and Cosoff Group as substantial shareholders. The 19 February 2026 change-in-substantial-holding filing failed verification, so later changes remain unknown.","reviewed_at":"2026-10-09T20:25:00Z","reviewed_through":"2025-10-20","status":"partial"}}},"review_digest":"5607bb3b9eac699eba0cb49c2cdf5425277061e76c647b4bcea0701b2aca410a","review_issues":[],"scan":{"failures":[],"last_collected_at":"2026-11-06T12:05:14.560934Z","profile":"valuation","scanned_through":"2026-11-06","ticker":"MEU"},"sources":{"2924-02673203-2A1453252":{"category":"director_interest","collected_at":"2026-10-09T20:25:38.638574Z","page_count":2,"published_at_utc":"2023-06-05T22:15:45Z","relative_path":"2023/2023-06-06_Change of Director's Interest Notice_8b1e84f07990bb90.pdf","review_note":"Reviewed both pages. Dr Colin Rose reports an on-market purchase of 747,386 ordinary shares during 30 May\u20132 June 2023 for A$23,946, with direct holdings changing from 98,719,726 to 99,467,112.","sha256":"7c264a183227841b34b14b5b5a201dc3e69fb211576ee918fc87267acc0ff014","source_id":"2924-02673203-2A1453252","state":"reviewed","subject_name":"Marmota Limited","subject_ticker":"MEU","title":"Change of Director's Interest Notice","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02673203-2A1453252"},"2924-02687505-2A1461659":{"category":"director_interest","collected_at":"2026-10-09T20:25:38.637829Z","page_count":2,"published_at_utc":"2023-07-17T22:16:51Z","relative_path":"2023/2023-07-18_Change of Director's Interest Notice_da31a4578d4915bd.pdf","review_note":"Reviewed both pages. Dr Colin Rose reports an on-market purchase of 1,150,000 ordinary shares on 17 July 2023 for A$43,117, with direct holdings changing from 99,467,112 to 100,617,112.","sha256":"9157bc620ba07994d1f9954f378578eac3de56ca4d542cd57681c18ef6e443d2","source_id":"2924-02687505-2A1461659","state":"reviewed","subject_name":"Marmota Limited","subject_ticker":"MEU","title":"Change of Director's Interest Notice","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02687505-2A1461659"},"2924-02689535-2A1462604":{"category":"director_interest","collected_at":"2026-10-09T20:25:38.636848Z","page_count":2,"published_at_utc":"2023-07-24T22:17:15Z","relative_path":"2023/2023-07-25_Change of Director's Interest Notice_7567b8a9093fb117.pdf","review_note":"Reviewed both pages. Dr Colin Rose reports an on-market purchase of 675,000 ordinary shares on 24 July 2023 for A$24,327, with direct holdings changing from 100,617,112 to 101,292,112.","sha256":"82c879c5a18ca1d008b8aa5328e2fbc8fc584c7f7d52260890997a6dfb45f6ec","source_id":"2924-02689535-2A1462604","state":"reviewed","subject_name":"Marmota Limited","subject_ticker":"MEU","title":"Change of Director's Interest Notice","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02689535-2A1462604"},"2924-02698243-2A1466769":{"category":"director_interest","collected_at":"2026-10-09T20:25:38.635979Z","page_count":2,"published_at_utc":"2023-08-16T22:05:44Z","relative_path":"2023/2023-08-17_Change of Director's Interest Notice_33764aa8c4ca546a.pdf","review_note":"Reviewed both pages. Dr Colin Rose reports an on-market purchase of 752,614 ordinary shares on 14 August 2023 for A$23,353, with holdings changing from 101,292,112 to 102,044,726 direct shares.","sha256":"a5dccf7caae00098a3fffa4de5c6221163382d5a50b525b4a05e2d77a5e5878d","source_id":"2924-02698243-2A1466769","state":"reviewed","subject_name":"Marmota Limited","subject_ticker":"MEU","title":"Change of Director's Interest Notice","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02698243-2A1466769"},"2924-02821000-2A1531195":{"category":"investment_release","collected_at":"2026-10-09T20:25:38.622277Z","page_count":1,"published_at_utc":"2024-06-25T22:23:30Z","relative_path":"2024/2024-06-26_$1,250,000 placement to key investors_1fb19c88a12c7104.pdf","review_note":"Reviewed the full placement announcement. It describes an issuer capital raising to key investors but does not name those investors or disclose any personal director/holder transaction.","sha256":"dad3d94bd61abe2f8003ceca695befebed7c21050c65f7ffbb7613b19196399d","source_id":"2924-02821000-2A1531195","state":"supporting","subject_name":"Marmota Limited","subject_ticker":"MEU","title":"$1,250,000 placement to key investors","triage":{"classification":"background_only","reason":"Issuer placement background only; no named director or substantial-holder transaction appears in the reviewed announcement.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-02821000-2A1531195"},"2924-03017299-2A1633061":{"category":"annual_report","collected_at":"2026-10-09T20:25:38.612767Z","page_count":81,"published_at_utc":"2025-10-31T00:46:08Z","relative_path":"2025/2025-10-31_Annual Report 2025.pdf","review_note":"Reviewed the full annual report, including director positions/options at the 25 September 2025 report date (pages 33\u201334) and substantial-holder positions as at 20 October 2025 (page 79). Position observations are captured; no trades are inferred from the report.","sha256":"2b726951d61d417f784b03a268e3f0bae393efa8b3268e1b9d7deab0f77739a7","source_id":"2924-03017299-2A1633061","state":"reviewed","subject_name":"Marmota Limited","subject_ticker":"MEU","title":"Annual Report 2025","url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03017299-2A1633061"},"2924-03055660-2A1653167":{"category":"investment_release","collected_at":"2026-10-09T20:25:38.607199Z","page_count":2,"published_at_utc":"2026-02-11T21:51:09Z","relative_path":"2026/2026-02-12_Marmota raises $15 million in highly successful placement_d51839f7920a77e5.pdf","review_note":"Reviewed the full placement announcement. It describes the issuer\u2019s capital raise and investor demand but names no individual holder or director transaction.","sha256":"307f33d3a8aa3dc1718a18607837f794ea28791f1c50ff1198ff7d775066d8dc","source_id":"2924-03055660-2A1653167","state":"supporting","subject_name":"Marmota Limited","subject_ticker":"MEU","title":"Marmota raises $15 million in highly successful placement","triage":{"classification":"background_only","reason":"Issuer placement background only; no named director or substantial-holder transaction appears in the reviewed announcement.","views":[]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03055660-2A1653167"},"2924-03089785-2A1671936":{"category":"security_event","collected_at":"2026-10-09T20:25:38.592406Z","page_count":6,"published_at_utc":"2026-05-13T07:18:01Z","relative_path":"2026/2026-05-13_Application for quotation of securities - MEU.pdf","review_note":"Reviewed the complete Appendix 2A. It identifies Company Secretary Lisa Askham-Levy as a KMP exercising 1,500,000 options but does not identify her as a director; no director transaction is recorded. The filing is retained as relevant classification context.","sha256":"3d34339aa6945a95cc5b3b7155856267947cacdd977cafb1718b292982303f2c","source_id":"2924-03089785-2A1671936","state":"supporting","subject_name":"Marmota Limited","subject_ticker":"MEU","title":"Application for quotation of securities - MEU","triage":{"classification":"relevant","reason":"Appendix 2A describes an employee-scheme exercise by a KMP who the annual report identifies as Company Secretary rather than a director; reviewed to assess scope and attribution.","views":["directors"]},"url":"https://asx.api.markitdigital.com/asx-research/1.0/file/2924-03089785-2A1671936"}},"status":"partial","summary":{},"ticker":"MEU","unresolved_count":0,"view":"major_holders","view_coverage":{"directors":{"basis":"declared","collection_issues":[],"coverage_start":"2023-01-01","explained_count":0,"material_issue_count":0,"minor_discrepancy_count":0,"newer_pending_count":1,"note":"Reviewed the four verified 2023 director purchase notices and 2025 annual-report position schedule. Later director notices were not available in verified form; the May 2026 KMP option exercise names the Company Secretary and is not treated as a director transaction.","notice_count":4,"pending_notice_count":0,"required_context_count":0,"reviewed_at":"2026-10-09T20:25:00Z","reviewed_notice_count":4,"reviewed_through":"2025-09-25","status":"partial","unclassified_note_count":0},"major_holders":{"basis":"declared","collection_issues":[],"coverage_start":"2023-01-01","explained_count":0,"material_issue_count":0,"minor_discrepancy_count":0,"newer_pending_count":1,"note":"Reviewed the 2025 annual-report snapshot naming Dr Colin Rose and Cosoff Group as substantial shareholders. The 19 February 2026 change-in-substantial-holding filing failed verification, so later changes remain unknown.","notice_count":1,"pending_notice_count":1,"required_context_count":0,"reviewed_at":"2026-10-09T20:25:00Z","reviewed_notice_count":0,"reviewed_through":"2025-10-20","status":"partial","unclassified_note_count":0}}}